Position in BIIB
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$518,823
+$18,308 QoQ
Shares Held
2,830
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CIM INVESTMENT MANAGEMENT INC holds $7,573,198 across 8 Drug Manufacturers - General names. BIIB ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,979 | $1,820,224 | |
| 2 | JNJ |
Johnson & Johnson
|
6,866 | $1,678,325 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,140 | $979,160 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
14,397 | $873,178 | |
| 5 | AMGN |
Amgen Inc
|
2,392 | $841,625 | |
| 6 | BIIB |
Biogen Inc.
This page
|
2,830 | $518,823 | |
| 7 | PFE |
Pfizer Inc
|
16,642 | $467,307 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,831 | $394,556 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $518,823 | 2,830 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $500,515 | 2,844 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $398,387 | 2,844 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $723,900 | 5,764 | Shares | Sole | 2025-08-22 | |
| 2025-03-31 | $395,057 | 2,887 | Shares | Sole | 2025-06-02 | |
| 2024-12-31 | $441,938 | 2,890 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $557,677 | 2,877 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $679,000 | 2,929 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $635,245 | 2,946 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $762,336 | 2,946 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $790,562 | 3,076 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $896,707 | 3,148 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $869,121 | 3,126 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $824,944 | 2,979 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,225,797 | 4,591 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $936,288 | 4,591 | Shares | Sole | 2022-09-02 | |
| 2022-03-31 | $971,919 | 4,615 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,108,430 | 4,620 | Shares | Sole | 2022-05-19 | |
| 2021-09-30 | $1,134,506 | 4,009 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $942,893 | 2,723 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $779,103 | 2,785 | Shares | Sole | 2021-05-20 | |
| 2020-12-31 | $1,414,801 | 5,778 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $398,854 | 1,406 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $379,653 | 1,419 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $448,943 | 1,419 | Shares | Sole | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||